News Daily News Surgical Aortic Valve Repair Effective, Durable in Experienced Hands Caitlin E. Cox December 21, 2017
Presentation TCT 2017 Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis! Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento November 01, 2017
Presentation TCT 2017 Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis! Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb November 01, 2017
Presentation TCT 2017 TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis! Presenter: A. Pieter Kappetein October 30, 2017
Presentation TCT 2017 Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis! Presenter: Susheel K. Kodali October 30, 2017
Presentation TCT 2017 Case Presentation: TAVR in Bicuspid Aortic Stenosis With Severe Calcification Presenter: Martin B. Leon, Yongjian Wu, Jun Jiang October 29, 2017
News Conference News PCR London Valves 2017 CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar Shelley Wood September 28, 2017
Presentation PCR London Valves 2017 Challenging TAVI Case of Bicuspid Aortic Stenosis Presenter: Praveen Chandra September 27, 2017
News Conference News PCR London Valves 2017 TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis Shelley Wood September 24, 2017
News Daily News One in 10 TAVR Patients Treated Off-Label: TVT Registry Michael O'Riordan June 22, 2017
Presentation TVT 2017 The Imaging Conundrum of Bicuspid Aortic Valve Disease - Almost 50 Shades of Gray! Presenter: Robert O. Bonow, Martin B. Leon, Nicolo Piazza June 15, 2017
News Conference News EuroPCR 2017 Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters Michael O'Riordan May 17, 2017
News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017